Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports

RATIONALE: Posterior reversible encephalopathy syndrome (PRES) has been associated with the use of several medications, including chemotherapeutic agents. PATIENT CONCERNS: A 65-year-old woman was diagnosed with adenocarcinoma of the ovary, after sixth-line treatment with topotecan, at the beginning...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacho-Díaz, Bernardo, Lorenzana-Mendoza, Nydia A., Salmerón-Moreno, Karen, Reyes-Soto, Gervith, Castillo-Rangel, Carlos, Corona-Cedillo, Roberto, Escobar-Ceballos, Salvador, de la Garza-Salazar, Jaime G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531111/
https://www.ncbi.nlm.nih.gov/pubmed/31083272
http://dx.doi.org/10.1097/MD.0000000000015691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531111/
https://www.ncbi.nlm.nih.gov/pubmed/31083272
http://dx.doi.org/10.1097/MD.0000000000015691

Ejemplares similares